CONNELLY STEPHEN (Chief Scientific Officer) sold 23.3% of their position (230.97K shares) of EQUILLIUM, INC. on the open market
Open‑market sale worth $723.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/5/2026ACC: 0001746808-26-000004
DirectorOfficer· Chief Scientific Officer
Since Oct 2018
-230.97K
Net shares
Net seller
$723.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
230.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−200K
Price / share
$3.16
Trade value
$632.76K
% of position
20.1%
6/4/2026
993K→793K
Common Stock
Direct
Shares
−30.98K
Price / share
$2.94
Trade value
$91.07K
% of position
3.9%
6/5/2026
793K→762.02K
Total
Net shares
−230.97K
Net value
-$723.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2026 | S · Sale | −200K | $3.16 | $632.76K | 20.1% | 993K | 793K |
| Common Stock Direct | 6/5/2026 | S · Sale | −30.98K | $2.94 | $91.07K | 3.9% | 793K | 762.02K |
| Total | −230.97K | -$723.83K | ||||||
Derivative Transactions0
No derivative transactions reported